PATENT CLAIM ANALYSIS

Application Number: 16135134
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "243100"]

Abstract:
The disclosure generally relates to the field of prevention and treatment of  Staphylococcus aureus  infections. In particular, the disclosure relates to immunogens comprising  Staphylococcus aureus  antigens and methods for generating immune reponses to immunogens, and to antibody products specific for the  Staphylococcus aureus  epitopes and methods for treating  Staphylococcus aureus  infection with the antibody products.

Claim (Index 11):
A method of treating  S. aureus  infection in a subject comprising administering to the subject an antibody product specific for:\n (i) an  S. aureus  alpha toxin epitope GFNGNVTGDDTGKIGGLIGAN (SEQ ID NO: 1), (ii) an  S. aureus  alpha toxin epitope consisting essentially of GNVTGDDTGKIGGLIG (SEQ ID NO: 14) or (iii) an immunogenic equivalent of the  S. aureus  alpha toxin epitope of (ii), wherein the immunogenic equivalent is a peptide consisting essentially of an amino acid sequence at least 90% identical to SEQ ID NO: 14.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.78788
- Patent Class: 424.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15511827', '15845701', '14440749', '13719214', '13983804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7399217213937636
- 35 USC 102 Novelty (BERT): 0.686982494204524
- Combined Prediction Score: 0.7346277986748396
- Mean Citation Score: 453.762476
- Max Citation Score: 742.5386
- Similarity Product: 656.2813511074186

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test